To test if the drug combination induced NETs in immune-competent mouse tumor models, we generated Pik3ca E545K oncogenic mutant knockin CMT93 and MC38 mouse colon cancer cell lines using CRISPR-mediated genome editing (Supplemental Figure 8, A and B). The gene discussed is PIK3CA; the disease is colonic neoplasm.